A 36-year-old man developed moderate-grade fever, headache, and malaise. On the third day, he noticed purpuric skin lesions and sought medical opinion. Investigations revealed a platelet count of 57 x 109/l and haematocrit of 64%. Several people in his locality and the city had similar illness with reported deaths. A diagnosis was made and he was treated with antipyretics for the next 3 days when he developed epistaxis, intense headache, and drowsiness. Cranial computed tomography (CT) (figures 1 and 2) was done and he was referred to this hospital for further management.
ebral oedema. Over the next 4 days, he became afebrile with a rise in platelet count to 130 x109/l. However, his neurological status deteriorated with increasing drowsiness, increase in left hemiparesis and bilateral extensor plantar response. A repeat cranial CT scan was not significantly different from the earlier one. In view of his neurological deterioration, he was subjected to a definitive procedure following which he steadily improved. Six months later he was doing well. The non-contrast cranial CT scan, axial cut, shows right-sided fronto-parietal subdural haematoma with midline shift, shifting of right choroid plexus anteriorly and medially, and complete obliteration of right lateral ventricle. The patient was subjected to a trephine craniotomy and evacuation of the haematoma. QUESTION 2 The primary disease was dengue haemorrhagic fever (DHF). The World Health Organisation (WHO) definition criteria for DHF during epidemics include fever, muco-cutaneous bleeding, thrombocytopenia, and haemoconcentration.' A definitive laboratory diagnosis requires virus isolation or serology. Polymerase-chainreaction-based diagnosis of the virus has also emerged as a reliable tool for diagnosis, although its routine use has yet to be evaluated. QUESTION 3 The pathogenesis of severe complications of dengue virus infections is not clear. Dengue virus infection confers lifetime immunity against re-infection with homologous serotypes, while increasing the susceptibility to other serotypes with a higher risk of complications, such as DHF and dengue shock syndrome (DSS). Studies from Thailand have demonstrated that 90% of all DHF/DSS cases occur with secondary dengue infection. Increased susceptibility to a heterologous serotype is mediated by antibody-dependent enhancement, ie, sub-neutralising concentrations of antibodies form complexes with the virus and thereby bind to the Fc-gammareceptor-positive cells such as monocytes through the Fc portion of the immunoglobulin molecule. This enhancement of infection increases the virus load and promotes pathogenesis of DHF/DSS. The secondary antibody response to viral antigens and cytotoxic effect of virus-specific cytotoxic T-lymphocytes sensitised from earlier infection also has an important role in the immunopathogenesis of DHF/DSS. The immune reaction involves activation of the classical complement pathway along with release of various cytokines resulting in increased vascular permeability, disseminated intravascular coagulation (DIC) and antibody-mediated destruction of platelets. These three features are responsible for most manifestations of DHF/DSS. QUESTION 4 The common causes of non-traumatic intracranial haemorrhage are given in box 1.
Discussion
Acute subdural haematoma usually results from head trauma. Non-traumatic (spontaneous) subdural haematoma is a rare form of intracranial bleeding. Risk factors for spontaneous subdural haematoma are hypertension2 and bleeding diathesis secondary to DIG due to cancer,3 cirrhosis of liver4 and anticoagulant 
